Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Cons Highest price per serving
Key Pen Needle Segment Allegations for Shareholders Pen needle share loss was concentrated at a single major customer, yet the Company described the segment as "incredibly resolute" weeks before the miss Market volume softness in the retail channel for insulin pens and pen needles contributed an estimated $20 million revenue shortfall Patients shifting purchases to lower-cost channels where Embecta does not participate created additional pressure unaddressed in guidance Share loss disproportionately affected patients not on preferred payer plans, amplifying the per-unit revenue impact beyond what average pricing suggested Inventory reductions at certain accounts and net pricing pressure added approximately $8 million in pen needle headwinds Syringe, swab, and safety product declines contributed an additional $22 million in revenue shortfall, of which approximately $13 million was from syringes, $5 million from discontinued swab products, and $4 million from safety products The Insulin Injection Market Context The global insulin delivery device market has been undergoing structural change
Ng specializes in a wide range of treatments, including injectables, laser therapies, and acne scar management
Sulfur Burps Some GLP-1 users report their burps smelling like sulfur
42 An additional concern specific to the psychiatric population, notably persons with established eating disorders, is the possibility of exacerbating symptoms of anorexia nervosa as well as obsessive-compulsive behavior
The choice between semaglutide and tirzepatide depends on your weight loss goals, budget, and tolerance
US$ 23.86
US$ 25.73
US$ 21.38
US$ 23.56
US$ 29.94
US$ 21.61
US$ 29.63
